Sharekhan is bullish on CESC has recommended buy rating on the stock with a target price of Rs 217 in its research report ...

This will be the biggest private equity backed IPO of 2024 and the fourth biggest to hit the Indian market in what has been a ...

Dabba trading platforms are aggressively promoting their no-margin and high-leverage products amid the market regulator's ...

When you need extra funds, the type of loan you choose can have a significant impact on your finances. Among the popular ...

Ajit Pawar is often described by various labels: a strong leader, a skilled administrator, a rebel, an opportunist, and even a corrupt individual.

MIT, the world’s second best university, is has taken a contrarian view of Indian markets when compared to other foreign ...

The UK has imposed sanctions on Iran for its role in supporting Russia’s war against Ukraine, as the world marks 1,000 days ...

We cut our estimates by 4-10% over the forecasted period to factor in the headwinds in the legacy Transfer Case business and ...

Jain noted that without significant large deals, growth will depend on a revival in discretionary spending, which remains ...

The 4,700kg GSAT-N2 High-throughput (HTS) satellite onboard a Falcon 9 rocket has been injected into the desired orbit, ...

Medi Assist Healthcare Services (CMP: Rs 558; Mcap: Rs 3,932 crore; Rating: Overweight), the only listed third-party ...

Sharekhan is bullish on Zydus Lifesciences has recommended buy rating on the stock with a target price of Rs 1078 in its ...